Clinical pharmacologists play crucial roles in local formularies and regional drug and therapeutics committees. At a national level, Clinical Pharmacology and Therapeutics consultants frequently occupy senior positions within bodies involved in drug regulation, including the National Institute for Clinical Excellence (NICE), the Medicines and Healthcare products Regulatory Agency (MHRA) and pharmacovigilance schemes (for example Yellow Card Centres).
Dr Daniel Marks
/Daniel-Marks.png.aspx?width=200&height=200 "Daniel-Marks.png") Dr Daniel Marks is a clinical lecturer and University College London, and an experimental medicine physician at GlaxoSmithKline. His typical week is split between the design and delivery of first-time-in-human and early phase drug trials in immunoinflammatory diseases.
"Working at the interface between clinical medicine and laboratory science is fascinating, and the ability to deliver new therapeutics for disease areas where there is substantial unmet need extremely rewarding. Developing new medicines is complex and challenging, and clinical pharmacologists are uniquely positioned to combine an understanding of patients with knowledge of chemistry and biology to produce novel, efficient and robust strategies for identifying new drug targets and indications, and turning molecules into therapeutics in the clinic, for patients"
Read more about Daniel's career path here
|